ONCO - Onconetix, Inc.
0.0677
-0.004 -6.352%
Share volume: 171,467,760
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
-0.06%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
-5.97%
1 Month
-62.80%
3 Months
-78.84%
6 Months
-78.84%
1 Year
-78.84%
2 Year
-78.84%
Key data
Stock price
$0.07
DAY RANGE
$0.06 - $0.11
52 WEEK RANGE
$0.06 - $0.34
52 WEEK CHANGE
-$78.84
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-14-2025
Company detail
CEO: Ralph Schiess
Region: US
Website: onconetix.gcs-web.com
Employees: 12
IPO year: 2022
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: onconetix.gcs-web.com
Employees: 12
IPO year: 2022
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Recent news
